Search results
The FAP provides comprehensive asthma care by ensuring access to guidelines-based medical management and pharmacotherapy for all Floridians with asthma and linking those with poorly controlled asthma to healthcare services.
- Asthma Management
Contact the Florida Asthma Program 850-245-4330...
- Asthma Data and Surveillance
Contact the Florida Asthma Program 850-245-4330...
- Disclaimer
Contact: Florida Health 850-245-4444 health@flhealth.gov...
- County Health Department Leadership
Contact: Florida Health 850-245-4444 health@flhealth.gov...
- Asthma Management
5 paź 2023 · Abstract. Obesity is a common asthma comorbidity in adults, contributing to higher patient morbidity and mortality. Conversely, weight loss can reduce the impact of obesity on asthma and improve patient outcomes by diverse mechanisms including modulating airway inflammation, reducing oxidative stress, and improving lung function.
The Bureau of Chronic Disease Prevention works towards a healthy Florida with the goal of reducing chronic conditions and diseases such as asthma, diabetes, disability, epilepsy, heart disease and stroke.
12 sie 2016 · Obesity is a risk factor for asthma, and obese asthmatics have lower disease control and increased symptom severity. Several putative links have been proposed, including genetics, mechanical restriction of the chest and the intake of corticosteroids.
Because obesity-associated asthma is less responsive to typical asthma medications, an integrated approach to the patient with comorbid obesity requires attention to obesity and its sequelae. Here, we summarize published experiences with dietary, behavioral, surgical, and pharmacologic interventions against obesity-associated asthma.
18 sie 2022 · Children with obesity who have asthma have greater severity and poorer control of their asthma symptoms, more frequent asthma exacerbations, and overall lower asthma-related quality of life than children with asthma who have a healthy weight.
Obesity-associated asthma is a unique phenotype which tends to be more severe and resistant to conventional asthma treatments. Differences in respiratory mechanics, inflammation, comorbidities, the microbiome, and susceptibility to air pollution may be contributory factors.
